Roche, Trump and drug pricing
Digest more
Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the United States
The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged to create these jobs between 2028 and 2032 at an average yearly salary of at least $119,800.
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North Carolina.
Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the United States amid President Donald Trump's tariff policies.
About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct a sprawling new plant for its Genentech unit in Holly Springs, North Carolina.
Explore more
The move is part of Roche’s previously announced plan to invest $50 billion in pharmaceuticals and diagnostics over the next five years in the United States. Roche Diagnostics, with its North America unit based in Indianapolis, is a maker of instruments to help physicians and laboratories test for a wide range of patient conditions.
The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that could change if certain yet-unspecified policies are implemented that could “harm our industry’s ability to operate and innovate in America.
AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international reputation, are delighted to announce the extension of their partnership for a
The National Health Insurance Authority has signed an expanded Memorandum of Understanding with a leading multinational healthcare company, Roche, to enhance access to affordable cancer care and treatment.